Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L39 pseudogene 39 (RPL39P39) is a non-functional genomic sequence that resembles the gene encoding ribosomal protein L39. As a pseudogene, it does not encode a protein, has no known biological function, and is not considered a drug target or a mediator of any human diseases. It is part of a large family of ribosomal protein gene pseudogenes dispersed in the genome as a consequence of evolutionary gene duplication events and retrotransposition[7][1][5]. There is no evidence to suggest that RPL39P39 (ribosomal protein L39 pseudogene 39) is a functional biological target or has relevance for drug discovery or therapeutic intervention. It should not be classified as a target in pharmacological or biomedical databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L39 pseudogene 39 (RPL39P39).